Literature DB >> 20416285

Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor.

Natália Bromberg1, Juliana L Dreyfuss, Caio V Regatieri, Marcelly V Palladino, Nelson Durán, Helena B Nader, Marcela Haun, Giselle Z Justo.   

Abstract

The continuing threat to biodiversity lends urgency to the need of identification of sustainable source of natural products. This is not so much trouble if there is a microbial source of the compound. Herein, violacein, a natural indolic pigment extracted from Chromobacterium violaceum, was evaluated for its antitumoral potential against the Ehrlich ascites tumor (EAT) in vivo and in vitro. Evaluation of violacein cytotoxicity using different endpoints indicated that EAT cells were twofold (IC(50)=5.0 microM) more sensitive to the compound than normal human peripheral blood lymphocytes. In vitro studies indicated that violacein cytotoxicity to EAT cells is mediated by a rapid (8-12h) production of reactive oxygen species (ROS) and a decrease in intracellular GSH levels, probably due to oxidative stress. Additionally, apoptosis was primarily induced, as demonstrated by an increase in Annexin-V positive cells, concurrently with increased levels of DNA fragmentation and increased caspase-2, caspase-9 and caspase-3 activities up to 4.5-, 6.0- and 5.5-fold, respectively, after 72 h of treatment. Moreover, doses of 0.1 and 1.0 microg kg(-1) violacein, administered intraperitoneally (i.p.) to EAT-bearing mice throughout the lifespan of the animals significantly inhibited tumor growth and increased survival of mice. In view of these results, a 35-day toxicity study was conducted in vivo. Complete hematology, biochemistry (ALT, AST and creatinine levels) and histopathological analysis of liver and kidney indicated that daily doses of violacein up to 1000 microg kg(-1) for 35 days are well tolerated and did not cause hematotoxicity nor renal or hepatotoxicity when administered i.p. to mice. Altogether, these results indicate that violacein causes oxidative stress and an imbalance in the antioxidant defense machinery of cells culminating in apoptotic cell death. Furthermore, this is the first report of its antitumor activity in vivo, which occurs in the absence of toxicity to major organs. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416285     DOI: 10.1016/j.cbi.2010.04.016

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  24 in total

1.  Expression, crystallization and preliminary crystallographic data analysis of VioD, a hydroxylase in the violacein-biosynthesis pathway.

Authors:  Tingting Ran; Mengxiao Gao; Qiaoe Wei; Jianhua He; Lin Tang; Weiwu Wang; Dongqing Xu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

2.  Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo.

Authors:  Laura Masuelli; Fabrizio Pantanella; Giuseppe La Regina; Monica Benvenuto; Massimo Fantini; Rosanna Mattera; Enrica Di Stefano; Maurizio Mattei; Romano Silvestri; Serena Schippa; Vittorio Manzari; Andrea Modesti; Roberto Bei
Journal:  Tumour Biol       Date:  2015-10-13

3.  Isolation and characterization of violacein from an Antarctic Iodobacter: a non-pathogenic psychrotolerant microorganism.

Authors:  Joaquin Atalah; Lotsé Blamey; Sebastian Muñoz-Ibacache; Felipe Gutierrez; Marcela Urzua; Maria Victoria Encinas; Maritza Páez; Junsong Sun; Jenny M Blamey
Journal:  Extremophiles       Date:  2019-07-19       Impact factor: 2.395

Review 4.  Multi-target drug with potential applications: violacein in the spotlight.

Authors:  Nelson Durán; Gerson Nakazato; Marcela Durán; Ignasio R Berti; Guillermo R Castro; Danijela Stanisic; Marcelo Brocchi; Wagner J Fávaro; Carmen V Ferreira-Halder; Giselle Z Justo; Ljubica Tasic
Journal:  World J Microbiol Biotechnol       Date:  2021-08-16       Impact factor: 3.312

5.  Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines.

Authors:  Bruna Neroni; Maria Antonella Zingaropoli; Giulia Radocchia; Maria Rosa Ciardi; Luciana Mosca; Fabrizio Pantanella; Serena Schippa
Journal:  Oncol Lett       Date:  2022-02-23       Impact factor: 2.967

6.  Investigation of potential inhibitor properties of violacein against HIV-1 RT and CoV-2 Spike RBD:ACE-2.

Authors:  Merve Ayse Dogancı; Fulya Ay Sal; Halil Ibrahim Guler; Hatice Katı; Esma Ceylan; Ali Osman Belduz; Gozde Bozdal; Nurettin Yaylı; Sabriye Canakcı
Journal:  World J Microbiol Biotechnol       Date:  2022-07-14       Impact factor: 4.253

7.  Violacein induces death of RAS-mutated metastatic melanoma by impairing autophagy process.

Authors:  Paola R Gonçalves; Karin J P Rocha-Brito; Maruska R N Fernandes; Julia L Abrantes; Nelson Durán; Carmen V Ferreira-Halder
Journal:  Tumour Biol       Date:  2016-08-08

8.  Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse.

Authors:  Karla C S Queiroz; Renato Milani; Roberta R Ruela-de-Sousa; Gwenny M Fuhler; Giselle Z Justo; Willian F Zambuzzi; Nelson Duran; Sander H Diks; C Arnold Spek; Carmen V Ferreira; Maikel P Peppelenbosch
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

9.  Violacein improves recombinant IgG production by controlling the cell cycle of Chinese hamster ovary cells.

Authors:  Masahide Kido; Hideaki Idogaki; Kouji Nishikawa; Takeshi Omasa
Journal:  Cytotechnology       Date:  2020-11-23       Impact factor: 2.040

Review 10.  Violacein: Properties and Production of a Versatile Bacterial Pigment.

Authors:  Seong Yeol Choi; Kyoung-hye Yoon; Jin Il Lee; Robert J Mitchell
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.